Think of the damage sophisticated cybercriminals—“hackers”—have caused in recent years. The pharmaceutical sector offers a sobering example, having weathered a steady barrage of cyberattacks over the past decade. More than ten years ago, the Dragonfly (aka “Energetic Bear”) espionage campaign targeted smaller pharma suppliers to steal intellectual property. By 2017, the NotPetya outbreak crippled Merck…